The global shortage of IV fluids continues to present significant challenges. At EBOS Healthcare, we remain committed to working collaboratively with our trusted partners to ensure the most reliable and consistent supply of essential products for our customers.

As communicated in October 2024, we continue to maintain provisional stock under Section 19A of the Therapeutic Goods Act 1989. Supporting documentation for these products is available on the respective product pages for your reference.

Sodium Chloride 0.9% Dual PP 100ml – [Approval under subsection 19A]
Sodium_Chlor_0.9%_Dual_PP_100ml_Approval_under_subsection_19A_product_code.pdf

Sodium Chloride 0.9% Dual PVC 100ml – [Approval under subsection 19A]
Sodium_Chlor_0.9%_Dual_PVC_1000ml_Approval_under_subsection_19A_10022744.pdf

We understand the critical importance of these products in clinical practice and remain steadfast in our efforts to mitigate the impact of these shortages.

Should you require further information or clarification, please do not hesitate to reach out to your Key Account Manager or contact our Customer Service team.

We greatly appreciate your continued understanding and cooperation as we navigate these challenges together.

Thank you,
EBOS Healthcare Team